tiprankstipranks
Advertisement
Advertisement

DWTX Stock Latest News

Dogwood enrolls first 200 patients in HAL-CINP trial
The FlyDogwood enrolls first 200 patients in HAL-CINP trial
11d ago
DWTX
Dogwood Therapeutics Shareholders Approve Key Governance Measures
PremiumCompany Announcements
Dogwood Therapeutics Shareholders Approve Key Governance Measures
1M ago
8K
DWTX
Dogwood begins Phase 2b extension study for Halneuron
PremiumThe Fly
Dogwood begins Phase 2b extension study for Halneuron
2M ago
DWTX
Dogwood announces commercialization partnership with PRIDCor
PremiumThe Fly
Dogwood announces commercialization partnership with PRIDCor
3M ago
DWTX
Dogwood announces FDA acceptance of SP16 investigational new drug application
PremiumThe Fly
Dogwood announces FDA acceptance of SP16 investigational new drug application
4M ago
DWTX
DWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsDWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
DWTX
Dogwood Therapeutics Highlights Pipeline Progress and Extended Runway
Premium
Company Announcements
Dogwood Therapeutics Highlights Pipeline Progress and Extended Runway
4M ago
8K
DWTX
Dogwood management to meet with Maxim
Premium
The Fly
Dogwood management to meet with Maxim
4M ago
DWTX
Dogwood sees cash runway into 4Q26
PremiumThe Fly
Dogwood sees cash runway into 4Q26
4M ago
DWTX
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
PremiumThe Fly
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
4M ago
DWTX
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
PremiumCompany Announcements
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
5M ago
8K
DWTX
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
PremiumRatings
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
6M ago
DWTX
Dogwood announces 50% enrollment in ongoing Halneuron Phase 2b trial
PremiumThe FlyDogwood announces 50% enrollment in ongoing Halneuron Phase 2b trial
6M ago
DWTX
Dogwood Therapeutics outlines 2026 plans for pain pipeline
Premium
Company Announcements
Dogwood Therapeutics outlines 2026 plans for pain pipeline
6M ago
8K
DWTX
Closing Bell Movers: JB Hunt down over 4% after soft Q1 sales
Premium
The Fly
Closing Bell Movers: JB Hunt down over 4% after soft Q1 sales
7M ago
C
BK
Dogwood files to sell 6.43M shares of common stock for holders
PremiumThe Fly
Dogwood files to sell 6.43M shares of common stock for holders
7M ago
DWTX
Dogwood Therapeutics Raises Capital via Registered Direct Financing
PremiumCompany Announcements
Dogwood Therapeutics Raises Capital via Registered Direct Financing
7M ago
8K
DWTX
Dogwood announces financing of up to $26.8M
PremiumThe Fly
Dogwood announces financing of up to $26.8M
7M ago
DWTX
Dogwood announces interim Phase 2b trial results on Halneuron
PremiumThe Fly
Dogwood announces interim Phase 2b trial results on Halneuron
7M ago
DWTX
Dogwood files for IP protection for synthetic Halneuron
PremiumThe FlyDogwood files for IP protection for synthetic Halneuron
8M ago
DWTX
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
Premium
Company Announcements
Dogwood Therapeutics Approves Equity Plan Amid Business Merger
8M ago
8K
DWTX
Dogwood enrolls first 100 patients in Halneuron Phase 2b trial
Premium
The Fly
Dogwood enrolls first 100 patients in Halneuron Phase 2b trial
9M ago
DWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >